{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:57:54Z","timestamp":1790827074150,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023262","name":"Jon Moulton Charity Trust","doi-asserted-by":"publisher","award":["1109891"],"award-info":[{"award-number":["1109891"]}],"id":[{"id":"10.13039\/501100023262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009128","name":"National Institute for Health Research Research for Patient Benefit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000388","name":"Saint Peter's Trust for Kidney Bladder and Prostate Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euros.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:04:53Z","timestamp":1788987893000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK"],"prefix":"10.1016","volume":"92","author":[{"given":"Jiunn","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Almeida\u2013Magana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Dinneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengning","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Leurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Brew\u2013Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-7505","authenticated-orcid":false,"given":"Elena","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.08.007_b0015","unstructured":"National prostate cancer audit. NPCA state of the nation report 2024; July 2025. https:\/\/www.npca.org.uk\/reports\/npca-state-of-the-nation-report-2024\/."},{"key":"10.1016\/j.euros.2026.08.007_b0020","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.euo.2023.11.021","article-title":"Assessing the impact of positive surgical margins on mortality in patients who underwent robotic radical prostatectomy: 20 years\u2019 report from the EAU Robotic Urology Section Scientific Working Group","volume":"7","author":"Pellegrino","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.08.007_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bco2.115","article-title":"Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy","volume":"3","author":"Vis","year":"2022","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euros.2026.08.007_b0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.eururo.2006.02.035","article-title":"Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy","volume":"49","author":"Eichelberg","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.08.007_b0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(25)00091-9","article-title":"Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trial","volume":"26","author":"Dinneen","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2026.08.007_b0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s13063-022-06421-7","article-title":"NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer","volume":"23","author":"Dinneen","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.euros.2026.08.007_b0045","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.euros.2026.08.007_b0050","series-title":"The economic evaluation of mental health care","first-page":"157","article-title":"Collecting and estimating costs","author":"Beecham","year":"1995"},{"key":"10.1016\/j.euros.2026.08.007_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"10.1016\/j.euros.2026.08.007_b0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.euros.2026.08.007_b0065","unstructured":"National Institute for Health and Care Excellence. NICE technology appraisal and highly specialised technologies guidance: the manual. March 31, 2026. https:\/\/www.nice.org.uk\/process\/pmg36."},{"key":"10.1016\/j.euros.2026.08.007_b0070","unstructured":"NHS England. 2023-25 NHS payment scheme (amended). April 4, 2025. https:\/\/www.england.nhs.uk\/publication\/2023-25-nhs-payment-scheme\/."},{"key":"10.1016\/j.euros.2026.08.007_b0075","unstructured":"National Institute for Health and Care Excellence. British National Formulary 2025. https:\/\/bnf.nice.org.uk\/."},{"key":"10.1016\/j.euros.2026.08.007_b0080","unstructured":"Jones KC, Weatherly H, Birch S, et al. Unit costs of health and social care 2023 manual. Technical report. Personal Social Services Research Unit. Centre for Health Economics, University of Kent and York, UK; 2024. https:\/\/doi.org\/10.22024\/UniKent\/01.02.105685."},{"key":"10.1016\/j.euros.2026.08.007_b0085","unstructured":"Office for National Statistics. Consumer price index 2025:2025. https:\/\/www.ons.gov.uk\/economy\/inflationandpriceindices\/bulletins\/consumerpriceinflation\/august2025."},{"key":"10.1016\/j.euros.2026.08.007_b0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"key":"10.1016\/j.euros.2026.08.007_b0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"van Hout","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.euros.2026.08.007_b0100","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s40273-023-01301-7","article-title":"Conducting trial-based economic evaluations using R: a tutorial","volume":"41","author":"Ben","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.euros.2026.08.007_b0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.euros.2026.08.007_b0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.euros.2026.08.007_b0115","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.euros.2026.08.007_b0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40273-018-0650-5","article-title":"Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis: a tutorial","volume":"36","author":"Leurent","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.euros.2026.08.007_b0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.319.7210.635","article-title":"Handling uncertainty in economic evaluations of healthcare interventions","volume":"319","author":"Briggs","year":"1999","journal-title":"BMJ"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326011808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326011808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:27:11Z","timestamp":1790825231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326011808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S2666168326011808"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.08.007","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}